ACST's CaPre Misses Goal Again, AIMT Snapped Up By Nestle, CRMD To Face FDA In Feb, VIR & COVID-19

Today's Daily Dose brings you news about Acasti Pharma's phase III trial of CaPre, Merger Monday, CorMedix's regulatory catalyst, Vanda Pharma's anticipated milestones, and the progress in Vir/Glaxo's COVID-19 trial.

from RTT - Biotech https://ift.tt/3jAjgkG
via IFTTT

Stock Alert: Akcea Therapeutics Soars 60%

Shares of Akcea Therapeutics, Inc. (AKCA) surged 60% on Monday after Ionis Pharmaceuticals agreed to buy remaining stake in Akcea for $500 million..

from RTT - Earnings https://ift.tt/2EAtfbc
via IFTTT

Acasti Pharma Says Phase 3 TRILOGY 2 Study Did Not Meet Primary Endpoint - Quick Facts

Biopharmaceutical company Acasti Pharma Inc. (ACST) announced Monday top-line results for the Primary Endpoint (triglyceride reduction at 12 and 26 weeks) from its 278 patient Phase 3 TRILOGY 2 study evaluating the efficacy, safety and tolerability of CaPre in patients with severe hypertriglyceridemia. The study did not meet its primary endpoint.

from RTT - Biotech https://ift.tt/2EGOoAn
via IFTTT

Pre-market Movers In Healthcare Sector: AIMT, HUGE, AMRN, EVFM, LPCN...

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/2QFAIIs
via IFTTT

Stock Alert: Ollie's Bargain Outlet Slips 5%

Shares of Ollie's Bargain Outlet Holdings, Inc. (OLLI) are currently slipping over 5% on Friday morning, despite the discount retailer reporting second-quarter results that trumped Wall Street estimates.

from RTT - Earnings https://ift.tt/32xR0IS
via IFTTT

Upward Momentum May Lead To Continued Strength On Wall Street

The major U.S. index futures are currently pointing to a higher open on Friday following the mixed performance seen in the previous session.

from RTT - Market Analysis https://ift.tt/2QE6GEB
via IFTTT

Pre-market Movers In Healthcare Sector: VBIV, ADMA, NBIX, ONCT...

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/3hBofRT
via IFTTT

Big Lots Does Not Re-instate FY20 Outlook; Declares Qtly. Cash Dividend Of $0.30/Shr - Quick Facts

While reporting financial results for the second quarter on Friday, discount retailer Big Lots, Inc. (BIG) said it is not in a position to re-instate its financial guidance for the full-year 2020 as it continues to believe it does not have sufficient visibility amidst the ongoing COVID-19 pandemic.

from RTT - Earnings https://ift.tt/3jrs0d7
via IFTTT

Dollar General, Dollar Tree And Abercrombie Q2 Results Top View, But Tiffany Sales Miss

Dollar General Corp.(DG) reported a profit for the second quarter that increased 84.6 percent from last year, while Dollar Tree Inc.'s (DLTR) quarterly profit rose 45 percent. Abercrombie & Fitch Co. (ANF) posted net income for the second-quarter compared to a net loss in the prior year. Tiffany & Co.'s (TIF) second-quarter profit dropped 76.6 percent.

from RTT - Earnings https://ift.tt/3hz8Cu7
via IFTTT

Stock Alert: NetApp Up 6% As Quarterly Results Beat Estimates

Shares of NetApp Inc. (NTAP) are rising more than 6 percent or $2.69 in Thursday's morning trade at $44.90, after the cloud storage software company's quarterly results beat estimates.

from RTT - Earnings https://ift.tt/34KBdZE
via IFTTT

UroGen Pharma: Phase 2 APOLLO Clinical Trial Did Not Meet Primary Endpoint

Biopharmaceutical company UroGen Pharma Ltd. (URGN) said Thursday that the Phase 2 APOLLO clinical trial of a RTGel hydrogel formulation in combination with Botox (onabotulinumtoxinA) intravesical instillation in patients with overactive bladder (OAB) and urinary incontinence did not meet the primary endpoint of the trial.

from RTT - Biotech https://ift.tt/2EzcnRT
via IFTTT

Futures Pointing To Modestly Lower Open Ahead Of Powell Speech

The major U.S. index futures are pointing to a modestly lower open on Thursday as traders await a highly anticipated speech by Federal Reserve Chair Jerome Powell.

from RTT - Market Analysis https://ift.tt/2QAGhrf
via IFTTT

Abercrombie & Fitch Q2 Profit Beats Estimates; Shares Surge

Abercrombie & Fitch Co. (ANF) reported second quarter adjusted net income per share of $0.23, compared to net loss per share of $0.48, last year. On average, 13 analysts polled by Thomson Reuters expected the company to report a loss per share of $0.83, for the quarter. Analysts' estimates typically exclude special items. The company's gross profit rate improved 140 basis points to 60.7% on lower promotional and clearance activity.

from RTT - Earnings https://ift.tt/3bdiYxz
via IFTTT

Lancaster Colony Q4 Profit Declines; Revenue Beats View

Lancaster Colony Corp. (LANC), a maker of specialty food products, on Thursday reported that its net income for the fourth quarter declined to $30.39 million or $1.10 per share from $33.01 million or $1.20 per share last year.

from RTT - Earnings https://ift.tt/32K4Qbh
via IFTTT

Sanderson Farms Q3 Profit Declines, But Results Top Estimates - Quick Facts

Sanderson Farms Inc. (SAFM) on Thursday reported net income for the third quarter of $32.81 million or $1.48 per share, lower than $53.36 million or $2.41 per share in the year-ago period.

from RTT - Earnings https://ift.tt/2YGsjIX
via IFTTT

Tiffany & Co. Q2 Profit Tops Estimates; Comps. Down 24% - Quick Facts

Tiffany & Co. (TIF) reported second quarter net earnings per share of $0.26 compared to $1.12, a year ago. Excluding items, second quarter earnings was $0.32 per share. On average, 11 analysts polled by Thomson Reuters expected the company to report profit per share of $0.19, for the quarter. Analysts' estimates typically exclude special items.

from RTT - Earnings https://ift.tt/3b0vCQc
via IFTTT

Dollar General Q2 Profit Tops Estimates; Same-store Sales Up 18.8%

Dollar General Corp. (DG) reported that its second quarter earnings per share increased 89.1% to $3.12 from $1.65, a year ago. EPS rose 79.3% from adjusted EPS of $1.74, prior year. On average, 25 analysts polled by Thomson Reuters expected the company to report profit per share of $2.44, for the quarter. Analysts' estimates typically exclude special items.

from RTT - Earnings https://ift.tt/3jk3A5g
via IFTTT

ReneSola Q2 Profit Declines, Revenues Nearly Double - Quick Facts

Solar project developer ReneSola Ltd. (SOL) reported Thursday that net income attributed to ReneSola for the second quarter declined to $3.09 million or $0.06 per share from $5.12 million or $0.13 per share in prior-year quarter.

from RTT - Earnings https://ift.tt/2EvNsPd
via IFTTT

Ossen Innovation H1 Profit, Revenues Decline - Quick Facts

Ossen Innovation Co., Ltd. (OSN), a China-based manufacturer of an array of plain surface, rare earth and zinc coated pre-stressed steel materials, said the company's net income declined 6.7% year-on-year for the six months ended June 30, 2020 because of the COVID-19 pandemic and China's economic slowdown during the period.

from RTT - Earnings https://ift.tt/34zy6nz
via IFTTT

Pre-market Movers In Healthcare Sector: EYPT, CLVS, ABT, VBIV, LPCN...

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/2EwNfLx
via IFTTT

Photronics Guides Q4 EPS, Revenues Below Estimates - Quick Facts

While reporting financial results for the third quarter on Thursday, semiconductor photomask maker Photronics, Inc. (PLAB) provided earnings and revenue guidance for the fourth quarter of fiscal 2020, below analysts' estimates.

from RTT - Earnings https://ift.tt/2QumbPv
via IFTTT

Will TOPAZ Add Sheen To Scholar Rock?

Shares of Scholar Rock Holding Corp. (SRRK) have gained nearly 39 percent in the last 1 month as the company gears up to report Spinal Muscular Atrophy trial data in the coming months.

from RTT - Biotech https://ift.tt/2QsZGdR
via IFTTT

Bouygues Posts Loss In H1; Sales Down 15% - Quick Facts

Bouygues (BOUYY.PK) reported a first half net loss attributable to the Group of 244 million euros compared to profit of 225 million euros, previous year. The Group reported a current operating loss of 132 million euros, compared to profit of 453 million euros. The company said the difference was entirely due to the impact of Covid-19, estimated at 650 million euros in first-half 2020.

from RTT - Earnings https://ift.tt/3gvqQev
via IFTTT

Biotech Stocks Facing FDA Decision In September

So far this year, 36 novel drugs have passed muster with the FDA compared to 26 during the same period (Jan- Aug) in 2019. Let's take a look at the companies that await a ruling from the FDA in September.

from RTT - Biotech https://ift.tt/3hsqJBT
via IFTTT

Stock Alert: Splunk Up 6% Ahead Of Q2 Earnings

Shares of Splunk Inc. (SPLK) are rising more than 6 percent or $12.35 in Wednesday's morning trade at $215.97.

from RTT - Earnings https://ift.tt/2EjxQOR
via IFTTT

Stock Alert: Urban Outfitters Surges 25% Driven By Strong Quarterly Results

Shares of Urban Outfitters Inc. (URBN) are gaining over 25% on Wednesday morning continuing its upward growth from last evening after the apparel retailer reported a second-quarter profit and sales that trumped Wall Street expectations driven largely by online sales.

from RTT - Earnings https://ift.tt/34yvar5
via IFTTT

Stock Alert: DICK'S Sporting Shares Up 12% In Early Trade On Upbeat Q2

Shares of DICK'S Sporting Goods Inc. (DKS) are rising over 12% in pre-market Wednesday morning, after the company stellar Q2 results.

from RTT - Before the Bell https://ift.tt/32sJfDR
via IFTTT

Looming Powell Speech May Lead To Choppy Trading

The major U.S. index futures are pointing to a roughly flat open on Wednesday following the mixed performance seen in the previous session.

from RTT - Market Analysis https://ift.tt/31vV2Ss
via IFTTT

Chico's FAS Q2 Loss Widens, Results Miss View - Quick Facts

Chico's FAS Inc. (CHS) reported Wednesday that its second-quarter net loss widened to $46.85 million or $0.40 per share from $2.31 million or $0.02 per share in the year-ago quarter.

from RTT - Earnings https://ift.tt/34zepMp
via IFTTT

Frito-Lay Recalls Lay's Barbecue Potato Chips For Undeclared Milk

Frito-Lay North America, the convenient foods division of PepsiCo, Inc., has recalled Lay's Barbecue Flavored Potato Chips citing the presence of undeclared milk, a known allergen. According to the U.S. Food and Drug Administration, the recall was initiated after it was discovered that certain bags of Lay's Barbecue Flavored Potato Chips were inadvertently filled with another flavor.

from RTT - Biotech https://ift.tt/2CYUsmU
via IFTTT

Pre-market Movers In Healthcare Sector: FLDM, IMUX, LPCN, SRNE, ZSAN.

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/31rTngO
via IFTTT

Dycom Industries Expects Q3 Revenues To Be In-line To Modestly Lower Than Q2 - Quick Facts

While reporting financial results for the second quarter on Tuesday, Dycom Industries, Inc. (DY) anticipates contract revenues and margins for the third quarter to range from in-line to modestly lower on a sequential basis for the second quarter, based on current conditions.

from RTT - Earnings https://ift.tt/3gpFJz6
via IFTTT

CYCN To Report IW-6463 Data In Sep, IMVT Hits New High, SRPT On Watch, MDWD Keeps Word To BARDA

Today's Daily Dose brings you news about the fund received by Cyclerion from Alzheimer's Association, Immunovant's myasthenia gravis trial meeting key goals, MediWound's first shipment of NexoBrid to BARDA, Ovid's ELEKTRA study results and Sarepta's regulatory catalyst.

from RTT - Biotech https://ift.tt/32ldXPi
via IFTTT

Bottom line for UK jobs is something needs to follow furlough scheme | Nils Pratley

Not all jobs can be saved, but a sudden crunch of layoffs would have multiplying effects

Tesco’s plan this week to create 16,000 jobs was a reminder that not every retail employer is shrinking its workforce, but the broader picture is unmistakable. Job cuts in the sector are happening at the fastest rate since 2009, according to the CBI’s monthly survey of “distributive trades”, and worse is expected in September.

In one small respect, the CBI’s finding is surprising. For all the sound and fury, the retail sector had a half-decent end to the summer. Retail sales rose above pre-pandemic levels in July, according to last week’s data from the Office for National Statistics, as pent-up demand was released with the end of lockdown. August’s numbers may also be reasonable since some of the “eat out to help out” punters will have visited a shop or two on their way to the restaurant.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/3aWgGm5

Stock Alert: J. M. Smucker Climbs 8% On Upbeat Q1 Results, Outlook

Shares of J M Smucker Inc. (SJM) are gaining almost 8 percent or $8.97 in Tuesday's morning trade at $121.96, after the food products maker reported better-than-expected financial results for the first quarter and also raised its outlook for fiscal 2021.

from RTT - Earnings https://ift.tt/3grXga2
via IFTTT

Stock Alert: Children's Place Plunge 20% On Quarterly Results

Shares of Children's Place Inc. (PLCE) tanked over 20% on Tuesday morning after the company reported a second-quarter loss that was wider than Wall Street analysts' estimates.

from RTT - Earnings https://ift.tt/2Qqa5Hi
via IFTTT

Stock Alert: Best Buy Down 6% On Outlook

Shares of Best Buy Inc. (BBY) are losing more than 6 percent or $7.11 in Tuesday's morning trade at $110.26, after the electronics retailer warned that its third-quarter sales will likely not continue at the current rate of growth.

from RTT - Earnings https://ift.tt/3lkmc6L
via IFTTT

Futures Pointing To Continued Strength On Wall Street

The major U.S. index futures are currently pointing to a higher open on Tuesday, with stocks likely to extend the upward move seen in the previous session.

from RTT - Market Analysis https://ift.tt/32o4E0T
via IFTTT

Best Buy Q2 Results Top Estimates; Declares Dividend

Electronics retailer Best Buy Co., Inc. reported Tuesday an 82 percent increase in profit for the second quarter from last year, primarily due to higher revenues and lower expenses. Both adjusted earnings per share and revenues for the quarter topped analysts' estimates. The company also said it is not providing financial guidance as a result of the ongoing uncertainty.

from RTT - Earnings https://ift.tt/2YOuAlF
via IFTTT

Takeda Pharma Says Phase 2 ELEKTRA Study Of Soticlestat Met Primary Endpoint

Japanese drug maker Takeda Pharmaceutical Co. Limited (TAK) and biopharmaceutical company Ovid Therapeutics Inc. (OVID) said that the randomized Phase 2 ELEKTRA study of Soticlestat in children with Dravet syndrome (DS) or Lennox-Gastaut syndrome (LGS) met the primary endpoint of reducing seizure frequency in the children.

from RTT - Biotech https://ift.tt/3jdQczr
via IFTTT

Hormel Foods Expects Q4 To Mirror Many Dynamics Of Q3 - Quick Facts

While reporting financial results for the third quarter on Tuesday, branded food company Hormel Foods Corp. (HRL) said it expects the fourth quarter to mirror many of the dynamics seen in the third quarter, including strength from our retail businesses and the ongoing recovery in our foodservice business.

from RTT - Earnings https://ift.tt/2YwqTkh
via IFTTT

Pre-market Movers In Healthcare Sector: OCGN, CERS, IBIO, KMDA, SONN.

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/3lh7nlG
via IFTTT

Aditx Files For EUA With FDA To Use AditxtScore For COVID-19 - Quick Facts

Life sciences company Aditx Therapeutics, Inc. (ADTX) announced Monday that it has submitted an Emergency Use Authorization (EUA) application with the U.S. Food and Drug Administration (FDA) for AditxtScore for COVID-19 to be used in detecting antibodies against SARS-CoV-2 antigens.

from RTT - Biotech https://ift.tt/2EsfwCS
via IFTTT

Stock Alert: Cancer Genetics Shares Skyrocket 213% In Early Trade

Shares of Cancer Genetics Inc. (CGIX) are soaring over 213% in pre-market today, after the company announced a definitive merger agreement with StemoniX Inc.

from RTT - Before the Bell https://ift.tt/2YtlWst
via IFTTT

Coronavirus Treatment News May Lead To Continued Strength On Wall Street

The major U.S. index futures are currently pointing to a higher opening on Monday, with the Nasdaq and the S&P 500 poised to reach new record highs.

from RTT - Market Analysis https://ift.tt/32jS82H
via IFTTT

Onconova: Phase 3 INSPIRE Trial Did Not Meet Primary Endpoint Of Improved Survival

Biopharmaceutical company Onconova Therapeutics, Inc. (ONTX) said Monday that INSPIRE, the company's pivotal Phase 3 study assessing the efficacy and safety of IV rigosertib in higher-risk myelodysplastic syndromes (MDS) or HR-MDS patients, did not meet its primary endpoint of improved survival.

from RTT - Biotech https://ift.tt/3gt7SFs
via IFTTT

Trevena Initiates TRV027 Study In COVID-19 Patients - Quick Facts

Biopharmaceutical company Trevena, Inc. (TRVN) announced Monday that the Imperial College London (ICL) has initiated a proof-of-concept study for TRV027 in COVID-19 patients. The company expects to report topline data in the first quarter of fiscal 2021.

from RTT - Biotech https://ift.tt/3aP0ROa
via IFTTT

Pre-market Movers In Healthcare Sector: SONN, ADMA, THMO, LMNL, KMDA...

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/3j9Sqje
via IFTTT

Stock Alert: Buckle Climbs 25% After Q2 Results Beat Estimates

Shares of Buckle Inc. (BKE) are rising more than 25 percent or $4.12 in Friday's morning trade at $20.49 after the apparel and footwear retailer reported better-than-expected earnings results for the second quarter.

from RTT - Earnings https://ift.tt/31fIcHV
via IFTTT

Stock Alert: Foot Locker Up 4% After Upbeat Q2 Results, Reinstating Dividend

Shares of Foot Locker Inc. (FL) are rising almost 4 percent or $1.02 in Friday's morning trade at $28.21, after the specialty athletic retailer's second-quarter results beat analysts' expectations and its board brought back the quarterly dividend program.

from RTT - Earnings https://ift.tt/2CNTHNB
via IFTTT

Profit Taking May Lead To Initial Pullback On Wall Street

The major U.S. index futures are currently pointing to a lower open on Friday, with stocks likely to give back ground after ending the previous session mostly higher.

from RTT - Market Analysis https://ift.tt/3l7Mp8r
via IFTTT

Target, Aldi Recall Wawona Peaches After Salmonella Outbreak

Retailers Target Inc. and Aldi are recalling peaches after they were linked to multistate outbreak of Salmonella Enteritidis infection that sickened at least 68 people in nine states. The recalls follow food safety warnings by the Food & Drug Administration, the Centers for Disease Control and Prevention, as well as state health officials against the consumption of fresh, whole peaches

from RTT - Biotech https://ift.tt/2E6l9qy
via IFTTT

Retail veterans lining up £6.5bn rival private equity bids for Asda

Either Rob Templeman or Paul Mason could possibly become chairman in a concluded deal

Two retail veterans are lining up to front rival £6.5bn private equity bids for Asda, the UK’s third largest supermarket.

Rob Templeman, a former chief executive of Debenhams, is understood to be assisting Apollo Global Management, while Paul Mason, a former Asda chief executive who also once led discount fashion group Matalan and the now defunct Somerfield supermarket, is linked to Lone Star Funds.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2YhIBaU

Stock Alert: Opera Down 23% On Quarterly Results

Shares of Opera Ltd. (OPRA) are currently losing over 23% on Nasdaq. The internet services provider's second-quarter revenues dropped 10% from last year.

from RTT - Earnings https://ift.tt/2Eq6Z2Y
via IFTTT

Unexpected Increase In Jobless Claims May Weigh On Wall Street

The major U.S. index futures are pointing to a lower open on Thursday, with stocks likely to see further downside after coming under pressure in afternoon trading on Wednesday.

from RTT - Market Analysis https://ift.tt/3gjxPqN
via IFTTT

Estée Lauder Guides Q1 Adj. EPS Below View; To Cut Up To 2000 Jobs - Quick Facts

While reporting financial results for the fourth quarter on Thursday, Estée Lauder Cos., Inc. (EL) provided earnings and sales growth guidance for the first quarter of fiscal 2021. However, the Company is not providing guidance for the full year 2021, given the uncertainty around the timing, speed and duration of the recovery from the adverse impacts of COVID-19.

from RTT - Earnings https://ift.tt/31eLw6s
via IFTTT

Alibaba Q1 Profit Rises; Domestic Core Commerce Business Recovers To Pre-COVID-19 Levels

Alibaba Group Holding Limited (BABA) said the company has delivered a very strong start to its new fiscal year, with revenue growing 34% year-over-year and adjusted EBITDA growing 30% year-over-year.

from RTT - Earnings https://ift.tt/34lkZpN
via IFTTT

Pre-market Movers In Healthcare Sector: KZIA, TRVN, SNSS, OCGN, GLPG...

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/2FHx3re
via IFTTT

JNJ Acquires MNTA, FDA Strikes Down BMRN's Gene Therapy, BLRX's GENESIS On Track, TPTX On Watch

Today's Daily Dose brings you news about the acquisition of Momenta by J&J, FDA refusing to approve BioMarin's hemophilia gene therapy, ThermoGenesis' COVID-19 combo kit getting red-flagged, Merck's Keytruda KEYNOTE-590 study meeting trial goals, the anticipated milestones of NuCana, and Turning Point's TRIDENT-1 study data.

from RTT - Biotech https://ift.tt/2QbBigM
via IFTTT

Stock Alert: OneSmart International Education Up 13% On Seeing Higher Revenue

Shares of OneSmart International Education Group Ltd. (ONE) are rising more than 13 percent or $0.72 in Wednesday's morning trade at $6.14, after the China-based tutoring service provider projected higher revenues for the fourth quarter and also affirmed its full-year revenue outlook.

from RTT - Earnings https://ift.tt/3kYbzGx
via IFTTT

Stock Alert: Q2 Results Takes Target To New 52-week High

Shares of Target Corp. (TGT) are higher by almost 10 percent or $13.32 in Wednesday's morning trade at $150.21, after earlier touching a new 52-week high of $150.89 as the retailer reported better-than-expected second-quarter results.

from RTT - Earnings https://ift.tt/2E6Ip7I
via IFTTT

Target Shares Surge On Record Q2 Results; Lowe's Q2 Profit Beats View

Minneapolis-based Target Corp. (TGT), on Wednesday, reported second-quarter results that surpassed analysts' projections. The company's comparable sales growth was the strongest it has ever reported. Consequently, shares of Target were up 8% in pre-market trade.

from RTT - Earnings https://ift.tt/2Q40SnT
via IFTTT

Progressive Corp. July Profit Soars 111% - Quick Facts

Insurer Progressive Corp. (PGR) reported that July net income soared 111 percent to $812.0 million or $1.38 per share from $384.9 million or $0.65 per share in the prior-year month.

from RTT - Earnings https://ift.tt/328SPvl
via IFTTT

Ampio Pharmaceuticals Updates On COVID-19 Clinical Trial Activities - Quick Facts

Biopharmaceutical company Ampio Pharmaceuticals, Inc. (AMPE) on Wednesday provided an update regarding the COVID-19 clinical trial activities.

from RTT - Biotech https://ift.tt/2DXwA3L
via IFTTT

Analog Devices Guides Q4 In Line With Estimates, Declares Dividend - Quick Facts

While reporting financial results for the third quarter on Wednesday, analog technology company Analog Devices Inc. (ADI) provided earnings and revenue guidance for the fourth quarter, in line with analysts' expectations.

from RTT - Earnings https://ift.tt/325OMjt
via IFTTT

Maison Terre Recalls Organic Goldenseal Root Powder

Maison Terre is recalling all lots of its Goldenseal Root Powder for microbial contamination, the U.S. Food and Drug Administration said in a statement. The recall was initiated after the FDA laboratory analysis of product samples found these products to be contaminated with various microorganisms. Maison Terre has received a report of one infant death associated with use of this product

from RTT - Biotech https://ift.tt/3gePOyG
via IFTTT

Pre-market Movers In Healthcare Sector: NMTR, VRNA, AXDX, GLPG...

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/3gaoiSY
via IFTTT

ALBO Drops NASH Drug Development, FDA Says No To Filgotinib, SUPN On Watch, Vanda & ODYSSEY

Today's Daily Dose brings you news about another headstone in the graveyard of NASH drugs, ADC Therapeutics' near-term catalysts, Gilead's Filgotinib being turned down by the FDA, Sorrento terminating its CFO, Supernus' regulatory catalyst for November, and Vanda's progress in COVID-19 treatment Tradipitant.

from RTT - Biotech https://ift.tt/2Yc3KDm
via IFTTT

Serafin Fishery Recalls Salmon Dip And Whitefish Dip

Serafin Fishery is recalling Salmon Dip and Whitefish Dip citing the possible presence of undeclared anchovies, eggs, milk and soy, known allergens, the U.S. Food and Drug Administration announced. The recall involves 8-ounce clear plastic containers of Salmon Dip and Whitefish Dips. The affected products were distributed locally in retail stores.

from RTT - Biotech https://ift.tt/2E37Nv3
via IFTTT

Walmart, Kohl's Q2 Results Tops Estimates

Retail giant Walmart Inc. (WMT) and department store chain Kohl's Corp. (KSS) on Tuesday reported a profit for the second quarter. Walmart's profit nearly doubled, while profit at Kohl's plunged from last year. Adjusted earnings per share and quarterly revenues at both Walmart's and Kohl's topped analysts' expectations.

from RTT - Earnings https://ift.tt/349txjr
via IFTTT

This Week's Healthcare IPOs

In the U.S, healthcare sector, five companies have already made their trading debut this month. Let's take a look at what's in store this week.

from RTT - Biotech https://ift.tt/3azqVN3
via IFTTT

Wall Street Might Aim Higher At Open

Stronger earnings reports of countrywide chain stores might influence the investors on Tuesday. Initial signs from the U.S. Futures Index suggest that Wall Street might open higher.

from RTT - Market Analysis https://ift.tt/2YdBjoF
via IFTTT

Walmart Q2 Adj. Profit Beats Estimates; Walmart U.S. ECommerce Sales Up 97%

Walmart Inc. (WMT) reported second quarter adjusted earnings per share of $1.56 compared to $1.27, a year ago. On average, 29 analysts polled by Thomson Reuters expected the company to report profit per share of $1.25, for the quarter. Analysts' estimates typically exclude special items. Adjusted operating income in constant currency increased 18.6% to $6.6 billion, led by strength across all operating segments, including significantly lower losses in Walmart U.S. eCommerce. Walmart said its second quarter net sales and operating results were significantly affected by the global health crisis. Increased demand for products across multiple categories led to strong top-line and gross margin results.

from RTT - Earnings https://ift.tt/2DTLuIj
via IFTTT

Pre-market Movers In Healthcare Sector: NMTR, TLSA, PTN, SRNE...

What's moving these stocks in the pre-market hours today?

from RTT - Biotech https://ift.tt/2Y9iZxa
via IFTTT

NVAX Begins Vaccine Trial In S.Africa, PSTX Slapped With Clinical Hold, UTHR To Face FDA In Apr.

Today's Daily Dose brings you news about Applied Therapeutics' ACTION-Galactosemia Kids trial being placed on partial hold by the FDA, Novavax initiating its COVID-19 vaccine trial in South Africa, Sanofi acquiring Principia Biopharma for $100 per share in cash, and FDA slapping a clinical hold on Poseida's prostate cancer trial after a patient's death, among others.

from RTT - Biotech https://ift.tt/313rZFI
via IFTTT

BHP FY Profit Down

BHP (BHP.AX, BLT.L, BBL, BHP) reported that its profit attributable to shareholders for the year ended 30 June 2020 decreased to US$7.96 billion or 157.0 US cents per share from US$8.31 billion or 159.9 US cents per share in 2019.

from RTT - Earnings https://ift.tt/3azy3cc
via IFTTT

Stock Alert: Progenity Rises 8%

Shares of Progenity Inc. (PROG) are higher by more than 8 percent or $0.63 in Monday's morning trade at $8.34 despite the biotechnology company reporting a wider loss for the second quarter.

from RTT - Earnings https://ift.tt/3h7TJ1B
via IFTTT

5 Biotech Stocks To Watch In The Coming Weeks (ALBO, ALNY, OTLK, MESO, CRBP)

The clinical trial results are one of the two major catalysts that affect the stock price of a biotech company, and more so if it is a small/mid-cap stock.In this article, we will discuss the anticipated near-term milestones of Albireo Pharma Inc. (ALBO), Alnylam Pharmaceuticals Inc. (ALNY), Corbus Pharmaceuticals Holdings Inc. (CRBP), Mesoblast Limited (MESO) and Outlook Therapeutics (OTLK).

from RTT - Biotech https://ift.tt/3kUZmSW
via IFTTT

CytoDyn Submits Top-line Report From Phase 2 Trial For COVID-19 Patients To FDA - Quick Facts

Biotechnology company CytoDyn Inc. (CYDY.OB) announced Monday that it has provided its Top-line Report from its recently completed, randomized, double-blind, Phase 2 trial for COVID-19 patients in the U.S. with mild-to-moderate symptoms to the U.S. Food and Drug Administration (FDA), and requested emergency use approval.

from RTT - Biotech https://ift.tt/30ZWkFg
via IFTTT

Pre-market Movers In Healthcare Sector: CLRB, SNOA, PRNB, LPCN, TLC...

What's moving these stocks in pre-market hours today?

from RTT - Biotech https://ift.tt/31SkAYY
via IFTTT

4 Stocks That Delivered Over 1,000% Returns

Russia has become the first nation to have approved a vaccine for COVID-19, formally registering it on August 11.

from RTT - Biotech https://ift.tt/340bWdO
via IFTTT

Uncertainty About Near-Term Outlook May Lead To Lackluster Trading

The major U.S. index futures are currently pointing to a mixed open on Friday, with stocks likely to extend the lackluster performance seen in the previous session.

from RTT - Market Analysis https://ift.tt/31Udwen
via IFTTT

China Pharma Swings To Profit In Q2 - Quick Facts

Specialty pharmaceutical company China Pharma Holdings Inc. (CPHI) reported Friday a net income for the second quarter of $0.01 million or $0.00 per share, compared to a net loss of $0.84 million or $0.02 per share in the prior-year quarter as a result of a foreign trade of COVID-19 testers completed in the second quarter of 2020.

from RTT - Earnings https://ift.tt/2POnx7o
via IFTTT

TLC Submits IND Application In Taiwan For TLC19 Inhalable Liposomal Hydroxychloroquine For COVID-19

Taiwanese specialty pharmaceutical company Taiwan Liposome Co. Ltd. (TLC) announced Friday the submission of an Investigational New Drug (IND) Application to the Taiwan Food and Drug Administration (TFDA) for TLC19 Hydroxychloroquine Liposome Inhalation Suspension for the treatment of coronavirus (COVID-19) disease.

from RTT - Biotech https://ift.tt/31ToNM6
via IFTTT

Pre-market Movers In Healthcare Sector: TFFP, NVAX, KMDA, PRPO, DVAX...

What's moving these stocks in pre-market hours today?

from RTT - Biotech https://ift.tt/3kLEvBy
via IFTTT

Fang Holdings Sees Positive Net Income For 2020 - Quick Facts

While reporting financial results for the second quarter on Friday, real estate Internet portal Fang Holdings Ltd. (SFUN) said its management predicts a positive net income for the year of 2020, based on current operations and market conditions. This represents the management's current and preliminary view and is subject to change.

from RTT - Earnings https://ift.tt/3gY3DCO
via IFTTT

China Automotive Systems Re-iterates FY20 Revenue Guidance - Quick Facts

While reporting financial results for the second quarter on Friday, vehicle parts supplier China Automotive Systems, Inc. (CAAS) re-iterated its revenue guidance for the full-year 2020 of $360 million, based on the company's current views on operating and market conditions, which are subject to change.

from RTT - Earnings https://ift.tt/33U9R34
via IFTTT

Kader Exports Recalls Frozen Cooked Shrimp For Salmonella Concerns

Kader Exports pvt. Ltd. is recalling certain consignments of various frozen cooked shrimp citing potential contamination with Salmonella, according to the U.S. Food and Drug Administration. The affected frozen cooked, peeled and deveined shrimp products were sold in 1lb, 1.5lb., and 2lb. retail bags. They were distributed from late February 2020 to Mid-May 2020 across the nation.

from RTT - Biotech https://ift.tt/2DXZ4dc
via IFTTT

FDA Panel Votes Overwhelmingly In Support Of Mesoblast's Allogeneic Cell Therapy

Mesoblast Limited (MESO) gave investors a pleasant surprise today, securing the FDA panel's overwhelming recommendation for its lead asset Ryoncil, proposed for pediatric steroid-refractory acute graft versus host disease. Not many would have expected Ryoncil to garner the advisory committee's positive vote after the release of the FDA briefing documents on August 10.

from RTT - Biotech https://ift.tt/3apHDyn
via IFTTT

Stock Alert: Varex Imaging Falls To New 52-week Low After Q3 Loss, Outlook

Shares of Varex Imaging Corp. (VREX) are losing more than 23 percent or $3.78 in Thursday's morning trade at $12.22, after earlier falling to a new 52-week low of $11.28 following weak third-quarter results.

from RTT - Earnings https://ift.tt/31QIEvo
via IFTTT

Drop In Jobless Claims May Lead To Initial Strength On Wall Street

The major U.S. index futures have edged higher on Thursday following the release of a report from the Labor Department showing first-time claims for U.S. unemployment benefits declined by much more than anticipated in the week ended August 8th.

from RTT - Market Analysis https://ift.tt/3gV5PLx
via IFTTT

Brookfield Asset Management Slips To Loss In Q2; Declares Dividend - Quick Facts

Brookfield Asset Management Inc. (BAM, BAM-A.TO) on Thursday reported a net loss for the second quarter attributable to shareholders of $656 million or $0.43 per share, compared to net income of $399 million or $0.24 per share in the year-ago quarter.

from RTT - Earnings https://ift.tt/31REOCt
via IFTTT

Tapestry Not Providing FY21 Outlook; Announces Acceleration Program For Profitability

While reporting financial results for the fourth quarter on Thursday, luxury accessories and lifestyle brand Tapestry Inc. (TPR) said it is not providing detailed guidance for fiscal 2021, due to the dynamic nature of the Covid-19 crisis and lack of visibility.

from RTT - Earnings https://ift.tt/2DMDUPm
via IFTTT

Deutsche Telekom Q2 EBITDA AL Climbs, Lifts FY20 View; Stock Up

Shares of Deutsche Telekom AG were gaining around 2 percent in the morning trade in Germany as the telecom giant raised fiscal 2020 outlook following the integration of newly acquired Sprint in the United States, along with significant growth in second-quarter EBIT and EBITDA AL, the key earnings metrics. Meanwhile, the second-quarter net profit declined from last year.

from RTT - Earnings https://ift.tt/2E1lQ3K
via IFTTT

Pre-market Movers In Healthcare Sector: BCRX, TTOO, DBVT, INO...

What's moving these stocks in pre-market hours today?

from RTT - Biotech https://ift.tt/3fO1hoM
via IFTTT

CureVac To Debut On Nasdaq Tomorrow

Founded in 2000, CureVac is a global clinical-stage biopharmaceutical company developing transformative medicines based on messenger ribonucleic acid (mRNA) technology for the development of prophylactic vaccines, cancer therapies, antibody therapies and the treatment of protein therapies.

from RTT - Biotech https://ift.tt/2PLfOqI
via IFTTT

Aegon H1 Profit Down 67%, Withdraws Outlook; Cuts Interim Dividend

Dutch life insurer Aegon NV (AGN.L, AEG) reported Thursday that for the first half of 2020, its net income fell 67 percent to 202 million euros from 617 million euros a year ago, reflecting one-time charge from assumption changes in the U.S.

from RTT - Earnings https://ift.tt/3kCujLI
via IFTTT

Goodman Group FY20 Operating Profit Up 12.5% - Quick Facts

Goodman Group (GMG.AX) reported Thursday that its statutory profit for fiscal 2020 was A$1.50 billion and includes the Group's share of valuation gains, non-cash items and derivative and mark to market movements.

from RTT - Earnings https://ift.tt/2Cm9nas
via IFTTT

Douglas 9-month Adj. EBITDA Down 10.6% - Quick Facts

German perfume and cosmetics retailer Douglas Group (DUGLY.PK, DUGLF.PK) Thursday reported that its adjusted EBITDA for the first nine months of fiscal 2019/20 decreased by 10.6 percent year-over-year to 264 million euros.

from RTT - Earnings https://ift.tt/3kIQKif
via IFTTT

Draegerwerk Turns To Profit In Q2; Affirms FY20 Outlook - Quick Facts

German medical and safety technology provider Draegerwerk AG & Co. KGaA (DRWKF.PK) reported Thursday that its second-quarter earnings before interest and taxes or EBIT was 102.2 million euros, compared to loss of 1.5 million euros in the year-ago period.

from RTT - Earnings https://ift.tt/2XR3oSH
via IFTTT

Nordex Group H1 Loss Widens; Sales Surge - Quick Facts

Gerrman wind turbine manufacturer Nordex Group (NRDXF.PK) said Thursday that for the first half of 2020, its earnings before interest, taxes, depreciation and amortization or EBITDA was negative 70.8 million euros, compared to 17.1 million euros in the prior-year period.

from RTT - Earnings https://ift.tt/30RE0y5
via IFTTT

VIE Joins COVID-19 Fight, CBMG To Be Taken Private, FDA Postpones Decision On EM-100, ONTX On Watch

Today's Daily Dose brings you news about Cellular Biomedicine to be taken private, delay in the FDA decision on Bausch Health's EM-100 proposed for the treatment of ocular itching associated with allergic conjunctivitis, progress in EyeGate's MoxiGel, a combination product for the treatment of bacterial conjunctivitis, and anticipated milestones of Onconova Therapeutics, among others.

from RTT - Biotech https://ift.tt/33Tgd2u
via IFTTT

Stock Alert: Boxlight Shares Soar 30% In Early Trade

Shares of Boxlight Corp. (BOXL) are currently trading at $2.62, up 61 cents or 30.35% in the pre-market session Wednesday. The stock has been trading in the range of $0.33 - $4.65 for the past one year, and closed Tuesday's regular trading session at $2.01, up 4 cents or 2.03%.

from RTT - Before the Bell https://ift.tt/3iAkHPS
via IFTTT

Stock Alert: Aemetis Shares Up 22% In Premarket

Shares of Aemetis Inc. (AMTX) are currently trading at $3.19, up 58 cents or 22.22% in the pre-market session Wednesday. The stock has been trading in the range of $0.37 - $2.94 for the past one year, and closed Tuesday's trade at $2.61, up 37 cents or 16.52%.

from RTT - Before the Bell https://ift.tt/3ahc6P0
via IFTTT

Airlines, Cruise And Tech Stocks May Lead Rebound On Wall Street

The major U.S. index futures are pointing to a higher open on Wednesday, with stocks likely to move back to the upside following the pullback seen late in the previous session.

from RTT - Market Analysis https://ift.tt/2PO3ZQF
via IFTTT

Performance Food Group Slips To Loss In Q4; Sales Top Estimates - Quick Facts

Performance Food Group Co. (PFGC) reported Wednesday a net loss for the fourth quarter of $151.2 million or $1.19 per share, compared to net income of $63.2 million or $0.60 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/3aiFp3D
via IFTTT

Brinker International Guides Q1 Loss Below Estimates - Quick Facts

While reporting financial results for the fourth quarter and fiscal 2020 on Wednesday, casual dining restaurant owner Brinker International, Inc. (EAT) provided guidance for the first quarter of fiscal 2021. However, the refrained from its usual practice of providing an annual outlook.

from RTT - Earnings https://ift.tt/2PNugym
via IFTTT

Pre-market Movers In Healthcare Sector: AZRX, ABUS, MRNA, MNK, TRVN.

What's moving these stocks in pre-market hours today?

from RTT - Biotech https://ift.tt/2DB1C1d
via IFTTT

Capital & Counties Properties H1 Loss Widens; Defers Dividend Decision

Capital & Counties Properties Plc or CAPCO (CAPC.L) reported Wednesday that its first half loss attributable to owners of the parent was 440.7 million pounds, wider than loss of 87.2 million pounds in the year-ago period. Basic loss per share was 51.7 pence, compared to loss of 10.2 pence a year ago.

from RTT - Earnings https://ift.tt/33Q7wGg
via IFTTT

Admiral Group H1 Profit Rises; Names Milena Mondini De Focatis Group CEO Designate

Car insurance provider Admiral Group Plc (ADM.L) reported Wednesday that its first-half profit before tax rose 31 percent to 286.1 million pounds from last year's 218.2 million pounds. Group's share of profit before tax was 286.7 million pounds, up 30 percent.

from RTT - Earnings https://ift.tt/3gVN5M0
via IFTTT

Spirax-Sarco H1 Pre-tax Profit Down 2%, Affirms FY Adj. Operating Profit Outlook

Industrial engineering group, Spirax-Sarco Engineering plc (SPX.L) reported Wednesday that its first-half profit before taxation declined 2 percent to 106.3 million pounds from last year's 108.1 million pounds. However, basic earnings per share rose 2 percent to 104.2 pence from 102.4 pence a year ago.

from RTT - Earnings https://ift.tt/2PIYq5M
via IFTTT

FDA Approves Genentech's Evrysdi To Treat Spinal Muscular Atrophy

The U.S. Food and Drug Administration approved the first oral drug to treat patients two months of age and older with spinal muscular atrophy (SMA) that can be taken at home. Roche subsidiary Genentech's Evrysdi (risdiplam) is also the second FDA-approved drug to treat this rare and often fatal genetic disease affecting muscle strength and movement.

from RTT - Biotech https://ift.tt/3ag0T1l
via IFTTT

Russian Claims About Coronavirus Vaccine May Generate Early Buying Interest

The major U.S. index futures are currently pointing to a higher open on Tuesday, with stocks likely to extend the upward trend seen in recent sessions.

from RTT - Market Analysis https://ift.tt/30LMfvt
via IFTTT

Macerich Declares Reduced Dividend; Not Providing Outlook - Quick Facts

While reporting financial results for the second quarter on Tuesday, REIT Macerich Co. (MAC) said its Board of Director's declared a reduced quarterly cash dividend of $0.15 per share of common stock, payable on September 8, 2020 to stockholders of record at the close of business on August 19, 2020.

from RTT - Earnings https://ift.tt/2XK4rUr
via IFTTT

United Internet Raises Sales Guidance For 2020 - Quick Facts

United Internet AG (UDIRF.PK) announced Tuesday that it is raising its sales guidance for the full-year 2020 in view of the development of business so far in 2020. However, it maintained EBITDA outlook for the full year.

from RTT - Earnings https://ift.tt/3gNN5gW
via IFTTT

Pre-market Movers In Healthcare Sector: EQ, PFNX, SRNE, SNSS, FENC...

What's moving these stocks in pre-market hours today?

from RTT - Biotech https://ift.tt/3kwcRsd
via IFTTT

Wegmans Recalls Valencia Oranges, Lemons For Listeria Concerns

Supermarket chain Wegmans Food Markets, Inc. is recalling select Valencia oranges, lemons, and various other products containing fresh lemon citing potential contamination with Listeria monocytogenes, the U.S. Food and Drug Administration announced. The recall was initiated after Wegmans' lemons and oranges supplier Freshouse Produce LLC, issued a recall of its supplies.

from RTT - Biotech https://ift.tt/3aqxHot
via IFTTT

CPRX Plunges As MuSK-MG Trial Flops, MESO Awaits FDA Panel Review, EQ Soars After-hrs

Today's Daily Dose brings you news about Seres Therapeutics' ECOSPOR trial data, acquisition of Pfenex by Ligand, Trevena's pain drug getting FDA nod, Reata update on investigational drug Omaveloxolone being developed for Friedreich's Ataxia, and disappointing results from Catalyst Pharma's MuSK-MG trial, among others.

from RTT - Biotech https://ift.tt/30KLoLt
via IFTTT

Stock Alert: Reata Pharmaceuticals Tanks 30% As Rare Genetic Disease Drug In Limbo

Shares of Reata Pharmaceuticals Inc. (RETA) tanked nearly 30% on Monday morning after the drug maker's Omaveloxoloneon, a drug being developed to treat a rare neurodegenerative disorder, hit a roadblock.

from RTT - Earnings https://ift.tt/33HdxVL
via IFTTT

Royal Caribbean Expects To Incur Loss In Q3, FY20 - Quick Facts

While reporting its financial results for the second quarter on Monday, Royal Caribbean Cruises Ltd. (RCL) said it expects to incur a net loss on both a U.S. GAAP and adjusted basis for its third quarter as well as fiscal year 2020, but noted that the extent of the loss will depend on the timing and extent of the return to service.

from RTT - Earnings https://ift.tt/2XOkaBI
via IFTTT

Futures Pointing To Initial Strength On Wall Street

The major U.S. index futures are currently pointing to a higher opening on Monday, although early buying interest may be somewhat subdued.

from RTT - Market Analysis https://ift.tt/3adP8s6
via IFTTT

FDA Approves Trevena's Olinvyk Opioid For Use In Hospitals

The U.S. Food and Drug Administration announced the approval of Trevena Inc.'s Olinvyk (oliceridine), a new opioid for intravenous use in hospitals or other controlled clinical settings. Olinvyk is an opioid agonist to manage moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative treatments are inadequate.

from RTT - Biotech https://ift.tt/3iv2Rhd
via IFTTT

Humanigen Expands Phase 3 Study Of Lenzilumab In COVID-19 To Brazil - Quick Facts

Biopharmaceutical company Humanigen, Inc. (HGEN) announced Monday that the Brazilian regulatory agency, Anvisa, has granted permission to commence a Phase 3 study of lenzilumab in patients with COVID-19 in Brazil.

from RTT - Biotech https://ift.tt/31wJMEo
via IFTTT

Pre-market Movers In Healthcare Sector: TRVN, ETON, FENC, OPGN.

What's moving these stocks in pre-market hours today?

from RTT - Biotech https://ift.tt/30NxfgR
via IFTTT

Black Knight Boosts FY20 Outlook - Quick Facts

While reporting financial results for the second quarter on Monday, Black Knight, Inc. (BKI), a provider of software, data and analytics solutions, raised its earnings and revenue guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/3iu2Qds
via IFTTT

Foot Locker Guides FY19 Adj. EPS Well Above Estimates; Shares Up 18% - Quick Facts

Provided sales and earnings update for the second quarter on Monday, specialty athletic retailer Foot Locker, Inc. (FL) announced that comparable store sales increased approximately 18 percent for the second quarter.

from RTT - Earnings https://ift.tt/3kvDzBi
via IFTTT

Roche's Evrysdi Approved By FDA For Treatment Of Spinal Muscular Atrophy

Roche (RHHBY) said the U.S. FDA has approved the company's Evrysdi (risdiplam) for the treatment of spinal muscular atrophy in adults and children 2 months of age and older. The company noted that Evrysdi is the first and only medicine for spinal muscular atrophy that can be taken at home. It will be available in the U.S. within two weeks for direct delivery to patients' homes through Accredo Health Group, an Express Scripts specialty pharmacy.

from RTT - Biotech https://ift.tt/3iqEGjT
via IFTTT

Stock Alert: First Solar Up 18% On Quarterly Results

Shares of First Solar, Inc. (FSLR) are gaining over 18% on Friday morning, after the company's second-quarter earnings and revenues trumped Wall Street expectations.

from RTT - Earnings https://ift.tt/30ze8XB
via IFTTT

Ferring Pharma US Recalls Nasal Sprays Due To Superpotency

Ferring Pharmaceuticals US is recalling various nasal sprays citing superpotency or amounts of desmopressin higher than specified, the U.S. Food and Drug Administration announced in a statement. The recall involves all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL.

from RTT - Biotech https://ift.tt/33y1IkF
via IFTTT

Pre-market Movers In Healthcare Sector: KZIA, ZSAN, BNGO, VXRT, ADTX...

What's moving these stocks in pre-market hours today?

from RTT - Biotech https://ift.tt/3klc5hv
via IFTTT

Magna International Re-instates FY20 Sales Outlook; Declares Dividend - Quick Facts

While reporting financial results for the second quarter on Friday, automotive supplier Magna International Inc. (MG.TO, MGA) re-instated its sales outlook for the full-year 2020, after it had withdrawn the outlook in late March, due to the high degree of business uncertainty caused by COVID-19.

from RTT - Earnings https://ift.tt/2PyeEyU
via IFTTT

Golden Minerals Q2 Loss Narrows, But Revenue Declines - Quick Facts

Golden Minerals Co. (AUMN, AUMN.TO) on Thursday reported net loss for the second quarter of $2.32 million or $0.02 per share, narrower than net loss of $2.46 million or $0.03 per share in the year-ago period.

from RTT - Earnings https://ift.tt/3fsSW9W
via IFTTT

Insight Enterprises Q2 Adj. Earnings Beats Estimates - Quick Facts

Insight Enterprises, Inc. (NSIT) on Thursday reported net earnings for the second quarter of $46.39 million or $1.32 per share, down from $50.00 million or $1.38 per share in the year-ago period.

from RTT - Earnings https://ift.tt/2DqBvtE
via IFTTT

Choice Hotels International Q2 Results Miss Estimates - Quick Facts

Choice Hotels International, Inc. (CHH) on Thursday reported net loss for the second quarter of $2.44 million or $0.04 per share, compared to net income of $74.39 million or $1.33 per share in the year-ago period.

from RTT - Earnings https://ift.tt/3a2ajND
via IFTTT

Weekly Jobless Claims Data Leads To Rebound By Stock Futures

The major U.S. index futures have rebounded after moving to the downside earlier this morning and are currently pointing to a slightly higher opening on Thursday

from RTT - Market Analysis https://ift.tt/3a5vRZJ
via IFTTT

American Electric Power Reaffirms FY20 Adj. EPS Outlook - Quick Facts

While reporting financial results for the second quarter on Thursday, electric utility American Electric Power Co., Inc. (AEP) reaffirmed its fiscal 2020 operating earnings guidance in the range of $4.25 to $4.45 per share. Including special items, estimated earnings would be between $4.20 and $4.40 per share.

from RTT - Earnings https://ift.tt/30vAZmW
via IFTTT

Flir Systems FY20 Outlook Remains Withdrawn - Quick Facts

While reporting its financial results for the second quarter on Thursday, Flir Systems Inc. (FLIR) said it has withdrawn its previously issued guidance for the full year ending December 31, 2020 due to the significant uncertainty generated by the COVID-19 pandemic.

from RTT - Earnings https://ift.tt/2EUqWzj
via IFTTT

Parker Hannifin Guides FY21 Above Estimates - Quick Facts

While reporting financial results for the fourth quarter on Thursday, Parker Hannifin Corp. (PH) initiated its earnings and adjusted earnings guidance for the full-year 2021, above analysts' expectations.

from RTT - Earnings https://ift.tt/3khV5J9
via IFTTT

Zoetis Q2 Results Beat Estimates; Raises And Narrows FY20 Outlook

Animal health company Zoetis Inc. (ZTS) on Thursday reported net income for the second quarter of $377 million or $0.79 per share, up from $371 million or $0.77 per share in the year-ago period.

from RTT - Earnings https://ift.tt/3acXm3T
via IFTTT

Lufthansa Stock Down On Q2 Loss, Profit Warning; Plans Steep Cost Cutting Measures

Shares of Deutsche Lufthansa AG were losing around 3 percent in German trading after the airline reported Thursday a loss in its second quarter, compared to prior year's profit with sharply lower revenues with collapse in demand for air travel due to the Corona pandemic. Going ahead, the airline projects a clearly negative adjusted EBIT in the second half of 2020 and a further significant decline

from RTT - Earnings https://ift.tt/2DpH3EI
via IFTTT

Cardinal Health Guides FY21 Adj. EPS In Line With View - Quick Facts

While reporting financial results for the fourth quarter on Thursday, healthcare services company Cardinal Health, Inc. (CAH) provided adjusted earnings guidance in a range of $5.25 to $5.65 per share.

from RTT - Earnings https://ift.tt/33wZCRT
via IFTTT

MAXIMUS Boosts FY20 Outlook; Declares Dividend - Quick Facts

While reporting financial results for the third quarter on Thursday, MAXIMUS, Inc. (MMS) raised its earnings and revenue guidance for the full year 2020, following new work wins and the expansion of existing work tied to the COVID-19 response, including the extension of the Census contract.

from RTT - Earnings https://ift.tt/3khZ1JY
via IFTTT

Lamar Advertising Re-initiates FY20 Earnings Outlook Below View - Quick Facts

While reporting financial results for the second quarter on Thurssday, outdoor advertising company Lamar Advertising Co. (LAMR) re-initiated its earnings and Adjusted Funds From Operations (AFFO) guidance for the full-year 2020 to incorporate the impact of the COVID-19 pandemic on its business.

from RTT - Earnings https://ift.tt/3ifg1P0
via IFTTT

Himax Technologies Issues Q3 Guidance - Quick Facts

While reporting financial results for the second quarter on Thursday, semiconductor company Himax Technologies Inc. (HIMX) provided earnings and revenue guidance for the third quarter of fiscal 2020.

from RTT - Earnings https://ift.tt/3fzmu5M
via IFTTT

Pre-market Movers In Healthcare Sector: AVXL, BEAM, AVGR, BMY...

What's moving these stocks in pre-market hours today?

from RTT - Biotech https://ift.tt/2PqYOpy
via IFTTT

Becton, Dickinson And Co. Re-initiates FY20 Outlook Below Estimates - Quick Facts

While reporting financial results for the third quarter on Thursday, medical technology company Becton, Dickinson and Co. or BD (BDX) re-initiated its adjusted earnings and revenue growth outlook for fiscal 2020.

from RTT - Earnings https://ift.tt/2Pvqh9G
via IFTTT

Mitsui Fudosan Q1 Profit Down 58.5% - Quick Facts

Mitsui Fudosan (MTSFY.PK) on Thursday reported first-quarter profit attributable to owners of parent of 13.77 billion yen, down 58.5 percent from 33.18 billion yen in the year-ago period. Earnings per share fell to 14.21 yen from 33.84 yen last year.

from RTT - Earnings https://ift.tt/39Zef1E
via IFTTT

Hammerson H1 Loss Widens; Announces Proposed Rights Issue, VIA Outlets Stake Sale

Hammerson plc (HMSO.L) reported Thursday that its first-half loss before tax widened to 1.09 billion pounds from 319.2 million pounds in the prior-year period. Loss per share widened to 142.2 pence from 41.8 pence in the year-ago period.

from RTT - Earnings https://ift.tt/3kh5qFd
via IFTTT

Aggreko Slips To Loss In H1; Names Mark Clarke As Chair Designate - Quick Facts

Aggreko plc (AGK.L) on Thursday reported loss before tax of 134 million pounds for the first half of fiscal 2020, compared to profit before tax of 60 million pounds a year ago. Loss per share was 57.75 pence, compared to earnings of 15.33 pence in the prior-year period.

from RTT - Earnings https://ift.tt/2C2nfXg
via IFTTT

EVRAZ H1 Profit Up 49.1%, But Revenue Declines - Quick Facts

Steel company EVRAZ plc (EVR.L) reported Thursday that its net profit for the first half of 2020 grew 49.1 percent to $513 million from $344 million last year. Earnings per share rose to $0.35 from $0.22 in the prior-year period.

from RTT - Earnings https://ift.tt/31q6spS
via IFTTT

Nikon Slips To Loss In Q1; Sees Loss For H1, Full Year - Quick Facts

Japanese image and video equipment manufacturer Nikon Corp. (NINOF.PK, NINOY.PK) reported Thursday that its first-quarter net loss attributable to owners of the parent was 13.59 billion Japanese yen, compared to net income of 8.20 billion yen in the same period last year. Loss per share was 37.03 yen, compared to earnings per share of 20.72 yen a year ago.

from RTT - Earnings https://ift.tt/3iecNvj
via IFTTT

Beiersdorf H1 Adj. EBIT, Sales Decline; Sees Negative Sales Growth In FY20

Nivea maker Beiersdorf AG (BDRFY.PK, BDRFF.PK) reported Thursday that its first-half earnings before interest and taxes and special factors or adjusted EBIT was 472 million euros, lower than last year's 593 million euros.

from RTT - Earnings https://ift.tt/3khF0mN
via IFTTT

ABIO To Start Phase 2 COVID-19 Trial In Q4, ACIU On Track, BCLI Expects ALS Trial Data In Nov.

Today's Daily Dose brings you news about ARCA biopharma's progress in its COVID-19 drug candidate, AC Immune' upcoming milestones, BrainStorm Cell's November catalyst, Bristol-Myers/Pfizer's Eliquis patent suit ruling, and Novavax's positive phase I data from its COVID-19 vaccine trial.

from RTT - Biotech https://ift.tt/2DzYRg6
via IFTTT

UniCredit Q2 Net Profit Down 77%; Confirms FY21 Profit Outlook - Quick Facts

Italian lender UniCredit SpA (UCG, UNCFF.PK) reported Thurday that its second-quarter net profit fell 77.4 percent to 420 million euros from last year's 1.85 billion euros.

from RTT - Earnings https://ift.tt/33ylNrc
via IFTTT

Stock Alert: Horizon Therapeutics Jumps 15% On Quarterly Results

Shares of Horizon Therapeutics Public Ltd. Co. (HZNP) are gaining over 15% on Wednesday morning after the company's second-quarter results trumped Wall Street view, driven by "tremendous" response for its drug Tepezza, a treatment for Thyroid Eye Disease. The company also lifted its full-year revenue outlook.

from RTT - Earnings https://ift.tt/2BZUhY2
via IFTTT

Stock Alert: Square Climbs To New 52-week High After Q2 Results

Shares of Square Inc. (SQ) are rising more than 14 percent or $19.75 in Wednesday's morning trade at $156.58, after earlier touching a new 52-week high of $158.43 as the payment processor reported increase in revenue for the second quarter.

from RTT - Earnings https://ift.tt/3frdL5r
via IFTTT

Stock Alert: New Relic Tumbles 24% After Q1 Results

Shares of New Relic, Inc. (NEWR) are losing almost 24 percent or $17.56 in Wednesday's morning trade at $55.94 after the software-as-a-service company reported a wider net loss for the first quarter.

from RTT - Earnings https://ift.tt/2XuM2KW
via IFTTT

BMW Stock Dips On Q1 Loss, FY2O Profit Warning

Shares of BMW AG were losing around 5 percent in German trading after the luxury car maker reported Wednesday a loss in its second quarter, compared to prior year's profit as demand was hit hard by coronavirus pandemic. Looking ahead, the company said it is cautiously optimistic for second half of the year, and reaffirmed fiscal 2020 outlook.

from RTT - Earnings https://ift.tt/31sdDho
via IFTTT

Optimism About Stimulus Bill May Generate Early Buying Interest

The major U.S. index futures are pointing to a higher open on Wednesday, with stocks likely to see further upside after ending yesterday's choppy trading session mostly higher.

from RTT - Market Analysis https://ift.tt/39V3b5M
via IFTTT

Allete Re-initiates FY20 Adj. EPS Outlook In Line With Estimates - Quick Facts

While reporting financial results for the second quarter on Wednesday, energy company Allete Inc. (ALE) re-initiated its adjusted earnings guidance for the full-year 2020, based on constructive indications of improving production from Minnesota Power's industrial customers.

from RTT - Earnings https://ift.tt/2PrA3cM
via IFTTT

BorgWarner Boosts FY20 Net Sales Outlook - Quick Facts

While reporting financial results for the second quarter on Wednesday, technology solutions provider BorgWarner Inc. (BWA) raised its net sales guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/30vrswg
via IFTTT

Advanced Energy Industries Guides Q3 Adj. EPS Above Estimates - Quick Facts

While reporting financial results for the second quarter on Wednesday, Advanced Energy Industries, Inc. (AEIS) provided earnings and revenue guidance for the third quarter.

from RTT - Earnings https://ift.tt/33uRyRB
via IFTTT

Gibraltar Industries Q2 Profit Rises; Results Beat Estimates - Quick Facts

Gibraltar Industries, Inc. (ROCK), a manufacturer and distributor of building products and services, reported Wednesday that its net income for the second quarter rose to $27.3 million or $0.83 per share from $19.9 million or $0.61 per share in the year-ago period.

from RTT - Earnings https://ift.tt/31A5Kqf
via IFTTT

Charles River Labs Boosts FY20 Outlook - Quick Facts

While reporting financial results for the second quarter on Wednesday, Charles River Laboratories International, Inc. (CRL) raised its earnings, adjusted earnings and revenue growth guidance for the full-year 2020, due to the better-than-expected second quarter performance and lower-than-expected revenue loss from the COVID-19 pandemic.

from RTT - Earnings https://ift.tt/2XwMGHZ
via IFTTT

Clean Harbors Re-establishes FY20 Outlook - Quick Facts

While reporting its financial results for the second quarter on Wednesday, Clean Harbors Inc. (CLH) said it is re-establishing its financial outlook for fiscal 2020.

from RTT - Earnings https://ift.tt/2XrzBzx
via IFTTT

Nielsen Holdings Boosts FY20 Adj. EPS Outlook - Quick Facts

While reporting its financial results for the second quarter on Wednesday, data analytics company Nielsen Holdings plc (NLSN) raised its adjusted earnings guidance for the full-year 2020, while trimming annual revenue outlook.

from RTT - Earnings https://ift.tt/2PqleqX
via IFTTT

Office Depot Q2 Loss Sharply Widens - Quick Facts

Office Depot Inc. (ODP), a provider of technology solutions to small, medium and enterprise businesses, reported Wednesday a net loss for the second quarter of $439 million or $8.19 per share, sharply wider than $24 million or $0.43 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/3ibI6XG
via IFTTT

Avista Confirms FY20 Earnings Outlook - Quick Facts

While reporting financial results for the second quarter on Wednesday, energy company Avista Corp. (AVA) confirmed its earnings per share guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/3gtUemg
via IFTTT

New York Times Issues Q3 Revenue Outlook; Q2 Profit Tops Estimates

The New York Times Company (NYT) said, for third quarter, total subscription revenues are estimated to increase approximately 10 percent compared with the third quarter of 2019, with digital-only subscription revenue to increase approximately 30 percent. Total advertising revenues are expected to decline approximately 35 percent to 40 percent, with digital advertising revenue to decrease approximately 20 percent, largely due to the impact from the COVID-19 pandemic. Other revenues are projected to decline approximately 10 percent year-on-year.

from RTT - Earnings https://ift.tt/33Ab3rY
via IFTTT

NiSource Guides FY21 Adj. EPS Below Estimates - Quick Facts

While reporting financial results for the second quarter on Wednesday, electric utility NiSource Inc. (NI) did not provide outlook for the full-year 2020, but initiated adjusted net operating earnings guidance for the full-year 2021.

from RTT - Earnings https://ift.tt/31rR7VU
via IFTTT

Humana Q2 Profit Tops Estimates; Maintains FY20 Adj. Earnings Guidance

Humana Inc. (HUM) reported second quarter adjusted earnings per share of $12.56 compared to $6.05, previous year. On average, 22 analysts polled by Thomson Reuters expected the company to report profit per share of $10.27, for the quarter. Analysts' estimates typically exclude special items.

from RTT - Earnings https://ift.tt/39VHrqe
via IFTTT

Blucora Initiates Q3, FY20 Outlook - Quick Facts

While reporting financial results for the second quarter on Wednesday, financial technology company Blucora, Inc. (BCOR) initiated earnings and revenue guidance for the third quarter and full-year 2020.

from RTT - Earnings https://ift.tt/39ZI561
via IFTTT

CVS Health Boosts FY20 Outlook - Quick Facts

While reporting financial results for the second quarter on Wednesday, CVS Health Corp. (CVS) raised its earnings and adjusted earnings guidance for the full-year 2020, reflecting an update to its estimated full year effective income tax rate.

from RTT - Earnings https://ift.tt/2DDara8
via IFTTT

H-E-B Recalls Blue Cheese Salmon Burgers For Undeclared Wheat

H-E-B has issued an all-store recall for Blue Cheese Salmon Burgers citing the presence of an undeclared allergen, the U.S. Food and Drug Administration announced. The products contain wheat, a known allergen, which is not declared on the product label. Consumers with allergy or severe sensitivity to wheat may get serious or life-threatening allergic reaction if they consume these products.

from RTT - Biotech https://ift.tt/2Xwtgmu
via IFTTT

Healthcare IPOs For August 6

In the healthcare sector, 14 companies made their debut on the NASDAQ last month. Let's take a look at the U.S. healthcare IPOs scheduled for tomorrow (August 6).

from RTT - Biotech https://ift.tt/31jqfHs
via IFTTT

Stock Alert: Cerence Hits New 52-week High

Shares of Cerence Inc. (CRNC), a provider of A.I. powered assistants and innovations for connected and autonomous vehicles, are rising almost 12 percent or $4.95 in Tuesday's morning trade at $46.43 after earlier touching a new 52-week high of $47.54.

from RTT - Earnings https://ift.tt/3i7zLnG
via IFTTT

Mallinckrodt Hints At Filing For Bankruptcy Protection

Shares of Mallinckrodt plc are losing more than 22 percent in pre-market activity on Tuesday after the biopharmaceutical company said it is likely to file for bankruptcy protection in the near-term. Mallinckrodt made the announcement while reporting its second-quarter results, saying it is exploring a range of options due to the several negative conditions and events impacting its business.

from RTT - Earnings https://ift.tt/3kadOWS
via IFTTT

Profit Taking May Contribute To Initial Weakness On Wall Street

The major U.S. index futures are currently pointing to a lower open on Tuesday, with stocks likely to give back ground following the strong upward move seen in the previous session.

from RTT - Market Analysis https://ift.tt/3i3tERm
via IFTTT

IPG Photonics Guides Q3 In Line With Estimates - Quick Facts

While reporting financial results for the second quarter on Tuesday, IPG Photonics Corp. (IPGP) provided earnings and revenues guidance for the third quarter, in line with analysts' estimates.

from RTT - Earnings https://ift.tt/2XsRttZ
via IFTTT

Nova Guides Q3 Adj. EPS In Line With View - Quick Facts

While reporting financial results for the second quarter on Tuesday, Nova Measuring Instruments Ltd. (NVMI) issued earnings and revenue guidance for the third quarter.

from RTT - Earnings https://ift.tt/2PjJZFk
via IFTTT

Element Solutions Q2 Results Beat Estimates - Quick Facts

Specialty chemicals company Element Solutions Inc (ESI) on Tuesday reported net income for the second quarter of $1.2 million or $0.01 per share, compared to $1.5 million or $0.01 per share in the year-ago period.

from RTT - Earnings https://ift.tt/3i1hp7K
via IFTTT

Vulcan Materials Says Not Reinstating FY20 Earnings Outlook - Quick Facts

While reporting its financial results for the second quarter on Tuesday, Vulcan Materials Co. (VMC),a producer of construction aggregates, said it is not reinstating its full-year earnings guidance at this time as the coronavirus pandemic's effect on demand and the broader economy remains unclear.

from RTT - Earnings https://ift.tt/2DuNgz1
via IFTTT

Vishay Intertechnology Guides Q3 Revenues Above Estimates - Quick Facts

While reporting financial results for the second quarter on Tuesday, semiconductor maker Vishay Intertechnology, Inc. (VSH) provided revenue guidance for the third quarter of fiscal 2020, above estimates, as recovering sales to automotive customers will compensate expected lower sales to Vishay's distribution partners.

from RTT - Earnings https://ift.tt/39Wen28
via IFTTT

Fraport Stock Down On H1 Loss, FY20 Warning; Plans Up To 4,000 Job Cuts

Shares of Fraport were losing around 4 percent in the German trading after the airport operator reported Tuesday a loss in its first half with sharply lower revenues, hurt by travel restrictions due to the coronavirus pandemic. Looking ahead for fiscal 2020, Group result is forecast to remain clearly negative, and Group EBIT is expected to be negative.

from RTT - Earnings https://ift.tt/2XpsA2v
via IFTTT

AA could be bought by private equity group as it battles £2.65bn debt

Motoring group’s shares rise after it says it has received three takeover approaches

The AA could be taken back into private equity ownership, as the motoring group said it was in talks with three suitors in an effort reduce its £2.65bn debt pile.

The firm, which was founded in 1905 as the Automobile Association, said it needed to raise funds to pay down its debts. With 3,000 patrol vehicles, the AA provides roadside assistance to 12 million members, including 3 million personal members, and also offers home and car insurance and driving lessons.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2DkWxK1

Emerson Boosts FY20 Outlook - Quick Facts

While reporting financial results for the third quarter on Tuesday, Emerson Electric Co. (EMR) raised its earnings and sales growth guidance for the full-year 2020, as cost savings take effect, demand begins to stabilize, and the economy begins to reopen.

from RTT - Earnings https://ift.tt/3iixZR1
via IFTTT

WEC Energy Reaffirms FY20 Earnings Outlook - Quick Facts

While reporting financial results for the second quarter on Tuesday, WEC Energy Group (WEC) reaffirmed its earnings guidance for the full-year 2020. This assumes normal weather for the remainder of the year.

from RTT - Earnings https://ift.tt/2DxHiNE
via IFTTT

Haemonetics Turns To Profit In Q1 - Quick Facts

Healthcare company Haemonetics Corp. (HAE) reported Tuesday a net income for the first quarter of $10.53 million or $0.21 per share, compared to a net loss of $8.48 million or $0.17 per share in the prior-year quarter. Excluding items, adjusted earnings were $0.46 per share, compared to last year's $0.81 per share.

from RTT - Earnings https://ift.tt/33nLmea
via IFTTT

Bio-Techne Q4 Results Top Estimates; Declares Dividend - Quick Facts

Life sciences company Bio-Techne Corp. (TECH) reported Tuesday that fourth-quarter net earnings surged to $58.85 million or $1.48 per share from $16.46 million or $0.42 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/30r662U
via IFTTT

Leidos Holdings Boosts FY20 Adj. EPS Outlook - Quick Facts

While reporting financial results for the second quarter on Tuesday, science and technology company Leidos Holdings Inc. (LDOS) raised its adjusted earnings guidance for the full-year 2020, while trimming annual revenue outlook.

from RTT - Earnings https://ift.tt/30smCzH
via IFTTT

Pre-market Movers In Healthcare Sector: ATHE, COCP, CHFS, EVFM, DBVT...

What's moving these stocks in pre-market hours today?

from RTT - Biotech https://ift.tt/39VHOkK
via IFTTT

ALRN To Report Data In Q4, IMUC Hits New High, VYGR Pulls Out Of ABBV Deal, VNDA To Face FDA In Dec.

Today's Daily Dose brings you news about the progress in Aileron's phase Ib clinical study of ALRN-6924, CymaBay's positive results from ENHANCE study, FDA approval of GW Pharma's Epidiolex for a new indication, Immunic's multiple sclerosis trial results, Rhythm Pharma's anticipated milestones, and the progress in the trial conducted by COVID R&D Alliance.

from RTT - Biotech https://ift.tt/33kTIU5
via IFTTT

Bayer Q2 EBITDA Before Special Items Rises, Sales Down 2.5%; Adjusts 2020 Forecast

The Bayer Group (BAYZF.PK, BAYRY.PK, BYR.L) reported a second quarter net loss of 9.548 billion euros due to special items for litigations compared to net income of 404 million euros, previous year. Loss per share was 9.72 euros compared to profit of 0.41 euros. EBIT was minus 10.78 billion euros compared to EBIT of 785 million euros, last year after net special charges of 12.511 billion euros. EBITDA before special items rose by 5.6 percent to 2.88 billion euros. Core earnings per share from continuing operations rose by 5.3 percent to 1.59 euros.

from RTT - Earnings https://ift.tt/2Post2w
via IFTTT

Jacobs Engineering Boosts FY20 Adj. EPS Outlook - Quick Facts

While reporting financial results for the third quarter on Monday, professional services provider Jacobs Engineering Group Inc. (JEC) raised its adjusted earnings outlook for the full-year 2020.

from RTT - Earnings https://ift.tt/39PwlmR
via IFTTT

Tech Stocks May Continue To Lead The Way Higher On Wall Street

The major U.S. index futures are currently pointing to a higher opening on Monday, with technology stocks likely to help lead the markets higher once again.

from RTT - Market Analysis https://ift.tt/3k6U0DR
via IFTTT

Tyson Foods Q3 Profit Tops Estimates; Names Dean Banks CEO

Tyson Foods, Inc. (TSN) reported third quarter adjusted net income per share attributable to company of $1.40 compared to $1.47, a year ago. On average, 12 analysts polled by Thomson Reuters expected the company to report profit per share of $0.94, for the quarter. Analysts' estimates typically exclude special items. Adjusted operating income declined year-on-year to $760 million from $796 million. The company noted that its results were negatively impacted by approximately $340 million of direct incremental expenses related to COVID-19.

from RTT - Earnings https://ift.tt/2XhCXoX
via IFTTT

CMS Energy Reaffirms FY20 Adjusted Earnings Outlook - Quick Facts

While reporting its financial results for the second quarter on Monday, CMS Energy Corp. (CMS) reaffirmed its adjusted earnings guidance for the full-year 2020.

from RTT - Earnings https://ift.tt/3gjAmSR
via IFTTT

EMCOR Group Re-initiates FY20 Outlook - Quick Facts

While reporting financial results for the second quarter on Monday, EMCOR Group, Inc. (EME) re-initiated its earnings and revenue guidance for the full-year 2020, based on year-to-date performance, current operating conditions and visibility into the remainder of the year.

from RTT - Earnings https://ift.tt/39UVMn4
via IFTTT

Ligand Pharmaceuticals Raises FY20 Outlook - Quick Facts

While reporting its financial results for the second quarter on Monday, Ligand Pharmaceuticals Inc. (LGND) said it now expects 2020 total revenues to be about $165 million and adjusted earnings per share to be $4.10, up from previous guidance for total revenues of approximately $140 million and adjusted earnings per share of $3.65.

from RTT - Earnings https://ift.tt/2XkFCxW
via IFTTT

AbbVie, Amgen, Takeda Pharma Enroll First Patients In I-SPY COVID Trial

AbbVie, Inc. (ABBV), Amgen Inc. (AMGN), and Takeda Pharmaceutical Co. Ltd. (TAK) said Monday that they have enrolled the first patients in the I-SPY COVID Trial (Investigation of Serial Studies to Predict Your COVID Therapeutic Response with Biomarker Integration and Adaptive Learning) clinical trial.

from RTT - Biotech https://ift.tt/33hOIzz
via IFTTT

Pre-market Movers In Healthcare Sector: IMUX, TRVN, VAR, VTGN.

What's moving these stocks in pre-market hours today?

from RTT - Biotech https://ift.tt/3a2yBHz
via IFTTT

Loews Slips To Loss In Q2 - Quick Facts

Loews Corp. (L) on Monday reported a second-quarter net loss of $835 million or $2.96 per share, compared to net income of $249 million, or $0.82 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/3gqncDt
via IFTTT

Beam Therapeutics - Yet To Shine

Shares of Beam Therapeutics Inc. (BEAM) have lost nearly 31 percent of their value over the past one month and trade around $19. The stock made its debut on the NASDAQ on February 6, 2020, and the IPO lock-up period is set to expire tomorrow (Aug. 4).

from RTT - Biotech https://ift.tt/2EHNrY9
via IFTTT

HSBC Q2 Profit Plunges, Warns Of Hefty Loan Losses; Stock Dips

Shares of HSBC Holdings Plc (HSBC, HSBA.L) were down in London and Hong Kong trading after the Asia-focused British lender reported Monday sharply lower profit in its second quarter, hurt by higher expected credit losses, weak revenues as well as the absence of prior year gain. For fiscal 2020, the company projects expected credit losses or ECL charge in the range of $8 billion to $13 billion.

from RTT - Earnings https://ift.tt/2PjCOwO
via IFTTT